Clinical Trial Update: Cilengitide (EMD 121974) in Treating Patients With Advanced Solid Tumors or Lymphoma [Phase 1]

View source ↗

Summary

Phase 1 trial update for cilengitide in patients with advanced solid tumors or lymphoma, with the study status reported as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aids-related Lymphoma
• Anaplastic Large Cell Lymphoma
• Burkitt Lymphoma
• Cns Lymphoma
• Diffuse Large B-cell Lymphoma
• Follicular Lymphoma
• Mantle Cell Lymphoma
• Marginal Zone Lymphoma

Drugs mentioned

• cilengitide (cilengitide)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: AIDS-related Peripheral/Systemic Lymphoma, AIDS-related Primary CNS Lymphoma | Phase 1 | Status: COMPLETED